Kingsview Wealth Management, LLC Amgen Inc Call Options Transaction History

Kingsview Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 50.0%	100 $0
Q2 2019 Jan 29, 2020	BUY	$166.7 - $195.41 $16,670 - $19,541	100 Added 100.0%	200 $3,000
Q4 2017 Jan 29, 2020	SELL	$168.79 - $188.59 $151,911 - $169,731	-900 Reduced 90.0%	100 $0
Q2 2017 Jan 29, 2020	BUY	N/A	1,000	1,000 $1,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.